Man-made enzymes - From design to in vitro compartmentalisation

Current Opinion in Biotechnology

Volumn 11, Issue 4, 2000, Pages 338-353

  Griffiths, Andrew D ^a   Tawfik, Dan S ^b  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b MRC CENTRE FOR PROTEIN ENGINEERING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME;

CATALYSIS; CATALYST; ENZYME ACTIVITY; ENZYME STRUCTURE; EVOLUTION; GENETIC ENGINEERING; GENOTYPE; LIBRARY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; TECHNIQUE;

EID: 0033908031     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(00)00109-9     Document Type: Review

References (84)

1. Branden C-I. Relationship between structure and function of α/β-proteins. Quart Rev Biophys. 13:1980;317-338.
2. Altamirano M.M., Fersht A.R. Combinatorial design principles in α/β-barrel proteins for the creation of novel biocatalysts. Proc Natl Acad Sci USA. 2000;. in press.
3. Gerlt J., Babbitt P. Mechanistically diverse enzyme superfamilies: the importance of chemistry in the evolution of catalysis. Curr Opin Chem Biol. 2:1998;607-612.
4. Petsko G.A., Kenyon G.L., Gerlt J.A., Ringe D., Kozarich J.W. On the origin of enzymatic species. Trends Biochem Sci. 18:1993;372-376.
5. Todd A.E., Orengo C.A., Thornton J.M. Evolution of protein function, from a structural perspective. Curr Opin Chem Biol. 3:1999;548-556.
6. M) towards AZT (versus the natural substrate thymidine) relative to the wild-type viral TKs.
7. Russell C.S., Clarke L.A. Recombinant proteins for genetic disease. Clin Genet. 55:1999;389-394.
8. Minshull J., Stemmer W.P. Protein evolution by molecular breeding. Curr Opin Chem Biol. 3:1999;284-290.
9. Arnold F.H., Volkov A.A. Directed evolution of biocatalysts. Curr Opin Chem Biol. 3:1999;54-59.
10. Cantor C.R. Biotechnology in the 21st century. Trends Biotechnol. 18:2000;6-7.
11. Lacroix E., Kortemme T., Lopez de la Paz M., Serrano L. The design of linear peptides that fold as monomeric beta-sheet structures. Curr Opin Struct Biol. 9:1999;487-493.
12. Corey M., Corey E. On the failure of de-novo designed peptides as biocatalysts. Proc Natl Acad Sci USA. 93:1996;11428-11434.
13. O'Brien P.J., Herschlag D. Catalytic promiscuity and the evolution of new enzymatic activities. Chem Biol. 6:1999;R91-R105. This review describes enzymes and non-catalytic proteins that catalyse reactions other than those involved in their normal biological activities. Promiscuous catalytic activities might have served as 'starting points' for the evolution of new enzymes in nature (via gene duplication and diversification) and could also be used for directed evolution in vitro.
14. Schiweck W., Skerra A. The rational construction of an antibody against cystatin: lessons from the crystal structure of an artificial Fab fragment. J Mol Biol. 268:1997;934-951.
15. Griffiths A.D., Duncan A.R. Strategies for selection of antibodies by phage display. Curr Opin Biotechnol. 9:1998;102-108.
16. Ostermeier M., Shim J.H., Benkovic S.J. A combinatorial approach to hybrid enzymes independent of DNA homology. Nat Biotechnol. 17:1999;1205-1209. A novel methodology is described (ITCHY) that creates combinatorial fusion libraries between genes in a manner that is independent of DNA homology (non-homologuous recombination).
17. Perelson A.S., Oster G.F. Theoretical studies of clonal selection: minimal antibody repertoire size and reliability of self-non-self discrimination. J Theor Biol. 81:1979;645-670.
18. Varga J.M., Kalchschmid G., Klein G.F., Fritsch P. Mechanism of allergic cross-reactions-I. Multispecific binding of ligands to a mouse monoclonal anti-DNP IgE antibody. Mol Immunol. 28:1991;641-654.
19. Lancet D., Sadovsky E., Seidemann E. Probability model for molecular recognition in biological receptor repertoires: significance to the olfactory system. Proc Natl Acad Sci USA. 90:1993;3715-3719.
20. Griffiths A.D., Williams S.C., Hartley O., Tomlinson I.M., Waterhouse P., Crosby W.L., Kontermann R.E., Jones P.T., Low N.M., Allison T.J.et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. Embo J. 13:1994;3245-3260.
21. de Haard H.J., van Neer N., Reurs A., Hufton S.E., Roovers R.C., Henderikx P., de Bruine A.P., Arends J.W., Hoogenboom H.R. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J Biol Chem. 274:1999;18218-18230.
22. Vaughan T.J., Williams A.J., Pritchard K., Osbourn J.K., Pope A.R., Earnshaw J.C., McCafferty J., Hodits R.A., Wilton J., Johnson K.S. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol. 14:1996;309-314.
23. Hollfelder F., Kirby A.J., Tawfik D.S. Efficient catalysis of proton transfer by synzymes. J Am Chem Soc. 119:1997;9578-9579.
24. Perutz M. Concluding remarks. Proc Roy Soc Lon. B167:1967;448.
25. Fersht A. Enzyme Structure and Mechanism. edn 2:1985;WH Freeman, New York.
26. Hollfelder F., Kirby A.J., Tawfik D.S. Off-the-shelf proteins that rival tailor-made antibodies as catalysts. Nature. 383:1996;60-62.
27. Szostak J.W., Wilson D.S. In vitro selection of functional nucleic acids. Annu Rev Biochem. 68:1999;611-647.
28. 13 variants were generated and selected for binding by creating mRNA-peptide fusions. In the future, very large protein and peptide libraries may be made routinely in vitro and selected for binding (Figure 2), and perhaps also for catalysis. For the time being, however, the phage-display libraries used in most binding selections, and in vivo selections for catalysis, rely on much smaller library sizes.
29. Altamirano M.M., Blackburn J.M., Aguayo C., Fersht A.R. Directed evolution of new catalytic activity using the alpha/beta-barrel scaffold. Nature. 403:2000;617-622. Phosphoribosylanthranilate isomerase (PRAI) activity was evolved from the scaffold of indole-3-glycerol-phosphate synthase (IGPS). In vitro mutagenesis and recombination followed by in vivo selection in an auxotrophic strain gave a new PRAI with catalytic properties that rival those of natural PRAI.
30. Bogarad L.D., Deem M.W. A hierarchical approach to protein molecular evolution. Proc Natl Acad Sci USA. 96:1999;2591-2595. An evolutionary experiment was simulated, in which a binding function was evolved by iterative rounds of mutation and selection starting from completely randomised 'libraries'. The Monte-Carlo simulations demonstrate that nonhomologous recombination is the rate-limiting step in the evolution of fold and binding function.
31. Smith G.P., Petrenko V.A. Phage display. Chem Rev. 97:1997;391-410.
32. Jermutus L., Ryabova L.A., Pluckthun A. Recent advances in producing and selecting functional proteins by using cell-free translation. Curr Opin Biotechnol. 9:1998;534-548.
33. Roberts R.W. Totally in vitro protein selection using mRNA-protein fusions and ribosome display. Curr Opin Chem Biol. 3:1999;268-273.
34. Schatz P.J., Cull M.G., Martin E.L., Gates C.M. Screening of peptide libraries linked to lac repressor. Methods Enzymol. 267:1996;171-191.
35. Georgiou G., Stathopoulos C., Daugherty P.S., Nayak A.R., Iverson B.L., Curtiss R. III Display of heterologous proteins on the surface of microorganisms: from the screening of combinatorial libraries to live recombinant vaccines. Nat Biotechnol. 15:1997;29-34.
36. Roberts R.W., Ja W.W. In vitro selection of nucleic acids and proteins: what are we learning? Curr Opin Struct Biol. 9:1999;521-529.
37. 9 variants) of subtiligase (a mutant of subtilisin that catalyzes the ligation of peptides) was displayed on phage and selected by the 'intramolecular single-turnover' mode (see Figure 3 and text). Some of the selected mutants had increased ligase activity (albeit ~2 fold), but the selection yielded mainly ligases with mutations that are correlated with increased stability and oxidative resistance of the protein.
38. Pedersen H., Holder S., Sutherlin D.P., Schwitter U., King D.S., Schultz P.G. A method for directed evolution and functional cloning of enzymes. Proc Natl Acad Sci USA. 95:1998;10523-10528.
39. Demartis S., Huber A., Viti F., Lozzi L., Giovannoni L., Neri P., Winter G., Neri D. A strategy for the isolation of catalytic activities from repertoires of enzymes displayed on phage. J Mol Biol. 286:1999;617-633. The paper describes model selections of enzymes displayed on phage by the 'intramolecular single-turnover' selection mode (Figure 3). The enzyme-substrate tethering was achieved non-covalently, by displaying calmodulin together with the enzyme and using substrates linked to a calmodulin-binding peptide.
40. Jestin J.L., Kristensen P., Winter G. A method for the selection of catalytic activity using phage display and proximity coupling. Angew Chem Int Ed. 38:1999;1124-1127. A model selection for a DNA-polymerase displayed on phage. The enzyme-product tethering was achieved after the reaction (i.e. the substrate was not tethered to the displayed enzyme), by proximity (the product, once formed, reacted with the phage).
41. Tawfik D.S., Griffiths A.D. Man-made cell-like compartments for molecular evolution. Nat Biotechnol. 16:1998;652-656.
42. Oberholzer T., Albrizio M., Luisi P.L. Polymerase chain reaction in liposomes. Chem Biol. 2:1995;677-682.
43. Lissant K. Emulsions and Emulsion Technology, vol 1-3. 1974;Marcel Dekker, New York.
44. Garti N., Aserin A. Pharmaceutical emulsions, double emulsions and microemulsions. Benita S. Microencapsulation: Methods and Industrial Applications. 1996;411-534 Marcel Dekker, New York.
45. Doi N., Yanagawa H. STABLE: protein-DNA fusion system for screening of combinatorial protein libraries in vitro. FEBS Lett. 457:1999;227-230. A library of biotinylated DNA, encoding peptides fused to streptavidin, was transcribed and translated in vitro in water-in-oil emulsions [41]. This resulted in a 'protein-DNA fusion' library that was subsequently selected for binding by affinity purification. This work demonstrated the application of in vitro compartmentalisation to create protein-display libraries and select them for binding, albeit with very limited efficiency.
46. Williams K., Bartel D. In vitro selection of catalytic RNA. Eckstein F., Lilley D. Nucleic Acids and Molecular Biology, vol 10: Catalytic RNA. 1996;367-381 Springer-Verlag, Berlin/Heidelberg.
47. Arkin M.R., Wells J.A. Probing the importance of second sphere residues in an esterolytic antibody by phage display. J Mol Biol. 284:1998;1083-1094.
48. Baca M., Scanlan T.S., Stephenson R.C., Wells J.A. Phage display of a catalytic antibody to optimize affinity for transition-state analog binding. Proc Natl Acad Sci USA. 94:1997;10063-10068.
49. Foote J., Eisen H.N. Kinetic and affinity limits on antibodies produced during immune responses. Proc Natl Acad Sci USA. 92:1995;1254-1256.
50. Stewart J.D., Benkovic S.J. Transition-state stabilization as a measure of the efficiency of antibody catalysis. Nature. 375:1995;388-391.
51. Kirby A.J. The potential of catalytic antibodies. Acta Chemica Scandinavica. 50:1996;203-210.
52. Schier R., McCall A., Adams G.P., Marshall K.W., Merritt H., Yim M., Crawford R.S., Weiner L.M., Marks C., Marks J.D. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. J Mol Biol. 263:1996;551-567.
53. Yang W.P., Green K., Pinz-Sweeney S., Briones A.T., Burton D.R., Barbas C.F. III CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J Mol Biol. 254:1995;392-403.
54. Hanes J., Jermutus L., Weber-Bornhauser S., Bosshard H.R., Pluckthun A. Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries. Proc Natl Acad Sci USA. 95:1998;14130-14135.
55. Tawfik D.S., Green B.S., Chap R., Sela M., Eshhar Z. catELISA: a facile general route to catalytic antibodies. Proc Natl Acad Sci USA. 90:1993;373-377.
56. Bensel N., Bahr N., Raymond M.T., Schenkels C., Reymond J.L. Catalytic antibodies by fluorescence screening. Helv Chim Acta. 82:1999;44-52.
57. Janda K.D., Lo L.C., Lo C.H.L., Sim M.M., Wang R., Wong C.H., Lerner R.A. Chemical selection for catalysis in combinatorial antibody libraries. Science. 275:1997;945-948.
58. 8 (exceptionally high for catalytic antibodies and comparable to natural aldolases) and efficient turnover.
59. Thomas N. Catalytic antibodies - reaching adolescence? Natural Products Rep. 1996;479-511.
60. Fastrez J. In vivo versus in vitro screening or selection for catalytic activity in enzymes and abzymes. Mol Biotechnol. 7:1997;37-55.
61. Santoro S.W., Joyce G.F. A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci USA. 94:1997;4262-4266.
62. Seelig B., Jaschke A. A small catalytic RNA motif with Diels-Alderase activity. Chem Biol. 6:1999;167-176.
63. Tarasow T.M., Tarasow S.L., Eaton B.E. RNA-catalysed carbon-carbon bond formation. Nature. 389:1997;54-57.
64. Crameri A., Dawes G., Rodriguez E. Jr., Silver S., Stemmer W.P. Molecular evolution of an arsenate detoxification pathway by DNA shuffling. Nat Biotechnol. 15:1997;436-438.
65. Gulick A.M., Fahl W.E. Forced evolution of glutathione S-transferase to create a more efficient drug detoxication enzyme. Proc Natl Acad Sci USA. 92:1995;8140-8144.
66. May O., Nguyen P.T., Arnold F.H. Inverting enantioselectivity by directed evolution of hydantoinase for improved production of L-methionine. Nat Biotechnol. 18:2000;317-320. The enantioselectivity and total activity of hydantoinase was increased by random mutagenesis and screening, thus leading to a significant improvement of a key enzyme in a 'whole-cell catalyst' producing L-methionine.
67. Kast P., Hilvert D. 3D structural information as a guide to protein engineering using genetic selection. Curr Opin Struct Biol. 7:1997;470-479.
68. Zhao H., Arnold F.H. Combinatorial protein design: strategies for screening protein libraries. Curr Opin Struct Biol. 7:1997;480-485.
69. Joo H., Lin Z., Arnold F.H. Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation. Nature. 399:1999;670-673. A sensitive throughput screen was applied to select mutants of P450 that hydroxylate naphthalene in the absence of cofactors and with more than 20-fold higher activity than the native enzyme.
70. Tawfik D.S., Green B.S., Eshhar Z. Detection of catalytic monoclonal antibodies. Anal Biochem. 202:1992;35-39.
71. Posner B., Smiley J., Lee I., Benkovic S. Catalytic antibodies: perusing combinatorial libraries. Trends Biochem Sci. 19:1994;145-150.
72. Radzicka A., Wolfenden R. A proficient enzyme. Science. 267:1995;90-93.
73. Harel M., Quinn D.M., Nair H.K., Silman I., Sussman J.L. The X-ray structure of a transition state analog complex reveals the molecular origins of the catalytic power and substrate specificity of acetylcholinesterase. J Am Chem Soc. 118:1996;2340-2346.
74. Herschlag D., Cech T.R. Catalysis of RNA cleavage by the Tetrahymena thermophila ribozyme. 1. Kinetic description of the reaction of an RNA substrate complementary to the active site. Biochemistry. 29:1990;10159-10171.
75. Matthews B.W., Craik C.S., Neurath H. Can small cyclic peptides have the activity and specificity of proteolytic enzymes? Proc Natl Acad Sci USA. 91:1994;4103-4105.
76. Li Y., Sen D. Toward an efficient DNAzyme. Biochemistry. 36:1997;5589-5599.
77. Lowman H., Wells J. Monovalent phage display: a method for selecting variant proteins from random libraries. Methods: A Companion to Methods in Enzymology. 3:1991;205-216.
78. Wirsching P., Ashley J.A., Lo C.H., Janda K.D., Lerner R.A. Reactive immunization. Science. 270:1995;1775-1782.
79. Fujii I., Fukuyama S., Iwabuchi Y., Tanimura R. Evolving catalytic antibodies in a phage-displayed combinatorial library. Nat Biotechnol. 16:1998;463-467.
80. Cochran A.G., Schultz P.G. Antibody-catalyzed porphyrin metallation. Science. 249:1990;781-783.
81. Conn M.M., Prudent J.R., Schultz P.G. Porphyrin metalation catalyzed by a small RNA molecule. J Am Chem Soc. 118:1996;7012-7013.
82. Li Y.F., Sen D. A catalytic DNA for porphyrin metallation. Nat Struct Biol. 3:1996;743-747.
83. Barbas C.F. III, Heine A., Zhong G., Hoffmann T., Gramatikova S., Bjornestedt R., List B., Anderson J., Stura E.A., Wilson I.A.et al. Immune versus natural selection: antibody aldolases with enzymic rates but broader scope. Science. 278:1997;2085-2092.
84. Pirrung M.C., Huang C.Y. A general method for the spatially defined immobilization of biomolecules on glass surfaces using "caged" biotin. Bioconjug Chem. 7:1996;317-321.